DICERNA PHARMACEUTICALS, INC.

(DRNA)
Temps Différé Nasdaq  -  27/12 22:00:00
38.22 USD   +0.58%
2021DICERNA PHARMACEUTICALS, INC. : Chardan Research neutre sur le dossier
ZM
2021Novo Nordisk conclut l'acquisition de Dicerna Pharmaceuticals
MT
2021NOVO NORDISK : a finalisé l'acquisition de Dicerna
CF
SynthèseCotationsGraphiquesActualitésNotationsSociétéFonds 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur DICERNA PHARMACEUTICALS, INC.
2021Dicerna Pharmaceuticals Coverage Dropped by Chardan After Novo Nordisk Closes Acquisiti..
2021DICERNA PHARMACEUTICALS, INC.(NASDAQ : DRNA) dropped from S&P Global BMI Index
2021DICERNA PHARMACEUTICALS, INC.(NASDAQ : DRNA) dropped from S&P TMI Index
2021DICERNA PHARMACEUTICALS, INC.(NASDAQ : DRNA) dropped from S&P Biotechnology Select Industr..
2021Novo Nordisk Completes Dicerna Pharmaceuticals Acquisition
2021DICERNA PHARMACEUTICALS : Novo Nordisk Announces Completion of Dicerna Pharmaceuticals Acq..
2021DICERNA PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice o..
2021Novo Nordisk Closes on $3.3 Billion Acquisition of Dicerna Pharmaceuticals
2021Novo Nordisk Announces Completion of Dicerna Pharmaceuticals Acquisition
2021DICERNA PHARMACEUTICALS, INC.(NASDAQ : DRNA) dropped from NASDAQ Composite Index
2021Dicerna Announces Expiration of Hart-Scott-Rodino Act Waiting Period for Novo Nordisk T..
2021DICERNA PHARMACEUTICALS, INC.(NASDAQ : DRNA) dropped from NASDAQ Biotechnology Index
2021INSIDER SELL : Dicerna Pharmaceuticals
2021SHAREHOLDER ALERT : Monteverde & Associates PC Announces an Investigation of Dicerna Pharm..
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
2021SHAREHOLDER ALERT : WeissLaw LLP Investigates Dicerna Pharmaceuticals, Inc.
2021Health Care Stocks Ending Little Changed in Quiet Trading
2021Health Care Stocks Weakening This Afternoon
2021SECTOR UPDATE : Health Care
2021Dicerna Shares Soar on Takeover by Novo Nordisk
2021SHAREHOLDER ALERT : Ademi LLP investigates whether Dicerna Pharmaceuticals, Inc. has obtai..
2021DICERNA MERGER INVESTIGATION : Halper Sadeh LLP Announces Investigation Into Whether the S..
2021Wall Street Set for Positive Open as Upbeat Nvidia Earnings Buoy Sentiment
2021DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 18.11.2021 - 15.15 Uhr
2021Health Care Stocks Edge Higher Premarket Thursday
2021Novo Nordisk übernimmt Biotechnologie-Unternehmen Dicerna Pharmaceuticals
2021SECTOR UPDATE : Health Care
2021DICERNA PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Other Events, Fi..
2021DICERNA PHARMACEUTICALS : Novo Nordisk to Acquire Dicerna - Form 8-K
2021Top Premarket Gainers
2021Novo Nordisk To Acquire Dicerna Pharmaceuticals
2021Dicerna Pharmaceuticals Enters $3.3 Billion Deal to Be Acquired by Novo Nordisk
2021Novo Nordisk to Buy Dicerna for $38.25 a Share
2021Novo Nordisk kauft für 3,3 Mrd USD Partner Dicerna Pharmaceuticals
2021Novo Nordisk to Acquire Dicerna
2021Dicerna Pharmaceuticals to Receive Multimillion-Dollar Milestone Payments Under Collabo..
2021DICERNA PHARMA : Two Targets in Lilly Collaboration Meet Proof of Principle
2021Dicerna Announces Two Targets Meet Preclinical Proof of Principle Criteria in Neurodege..
2021Dicerna Presents Data From Phase 1 Trial of Belcesiran at American Association for the ..
2021Dicerna Pharmaceuticals, Inc. Presents Data from Phase 1 Trial of Belcesiran At America..
2021Dicerna Pharmaceuticals Narrows Q3 Net Loss as Revenue Rises
2021TRANSCRIPT : Dicerna Pharmaceuticals, Inc., Q3 2021 Earnings Call, Nov 09, 2021
2021Dicerna Announces Third Quarter 2021 Financial Results and Provides a Business Update -..
2021DICERNA PHARMACEUTICALS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIO..
2021DICERNA PHARMACEUTICALS : Q3 Earnings Snapshot
2021DICERNA PHARMACEUTICALS INC : Results of Operations and Financial Condition (form 8-K)
2021Earnings Flash (DRNA) DICERNA PHARMACEUTICALS Posts Q3 Revenue $63M, vs. Street Est of ..
2021Dicerna Announces Third Quarter 2021 Financial Results and Provides a Business Update
2021Dicerna Presents PHYOX2 and Primary Hyperoxaluria Healthcare Utilization Data at Americ..
2021 Dicerna Presents PHYOX™2 and Primary Hyperoxaluria Healthcare Utilization Data a..
2021Dicerna Pharmaceuticals, Inc. Presents PHYOX?2 and Primary Hyperoxaluria Healthcare Uti..
2021Dicerna to Report Third Quarter 2021 Financial Results on Nov. 9, 2021
2021DICERNA PHARMACEUTICALS : Announces Results for PHYOX4, Single-Dose Study of Nedosiran in ..
2021DICERNA PHARMACEUTICALS : Says Hyperoxaluria Treatment Met Safety Endpoint in Trial But Mi..
2021DICERNA PHARMACEUTICALS : Announces Results for PHYOX™4, Single-Dose Study of Nedosi..
2021Dicerna Announces Results for PHYOX™4, Single-Dose Study of Nedosiran in Primary Hypero..
2021DICERNA PHARMACEUTICALS : Announces Data to Be Presented at American Society of Nephrology..
2021DICERNA PHARMACEUTICALS : to Present Phase 1 Data for Two Drug Candidates at Liver Disease..
2021DICERNA PHARMACEUTICALS : Announces Poster Presentations at American Association for the S..
2021Dicerna Pharmaceuticals, Inc. Announces Poster Presentations at American Association fo..
2021DICERNA PHARMACEUTICALS : Corporate Overview
2021DICERNA PHARMACEUTICALS : Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2021DICERNA PHARMACEUTICALS : Initiates Phase 1 Clinical Trial of DCR-AUD, a Novel Investigati..
2021DICERNA PHARMACEUTICALS : Begins Early-Stage Trial of Potential Treatment for Alcoholic Us..
2021DICERNA PHARMACEUTICALS : Initiates Phase 1 Clinical Trial of DCR-AUD, a Novel Investigati..
2021Dicerna Pharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of DCR-AUD
2021DICERNA PHARMACEUTICALS : Names Rob Ciappenelli Chief Strategy Officer
2021DICERNA PHARMACEUTICALS : Announces New Executive Leadership Appointments
2021Dicerna Pharmaceuticals, Inc. Announces Executive Appointments
2021INSIDER SELL : Dicerna Pharmaceuticals
2021TRANSCRIPT : Dicerna Pharmaceuticals, Inc. Presents at Citi’s 16th Annual BioPharma V..
2021DICERNA PHARMACEUTICALS : Corporate Overview
2021DICERNA PHARMACEUTICALS : to Participate in 16th Annual Citi Biopharma Conference
2021DICERNA PHARMACEUTICALS : Corporate Overview
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
1  2  3  4  5  6  7  8  9  10Suiv.